First AD

Second AD

Genitourinary Cancers

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

The Evolving Treatment Landscape of Renal Cell Carcinoma: Highlights from ESMO 2022 and Beyond 

Peer Exchange

Moving on to discuss the management of non–clear cell renal cell carcinoma, panelists consider cornerstone treatment options in this setting.

Systemic Therapy in the Treatment of Non-Clear Cell RCC: The Evolving Landscape

Overview on Clear Cell Renal Cell Carcinoma: Prevalence and Prognosis 

What is the Role of Nephrectomy in Advanced Clear Cell RCC?

Selecting the Appropriate First-Line Therapy in Advanced Clear Cell RCC 

Advanced Clear Cell RCC: Role of Site of Metastases in Selecting First-Line Therapy

Treating Patients with Clear Cell RCC with Brain Metastases or Sarcomatoid Disease 

Advanced Clear Cell RCC: Quality of Life Data in First-Line Clinical Trials

First-Line Therapy in Advanced Clear Cell RCC: Novel Doublet Regimens

First-Line Therapy in Advanced Clear Cell RCC: Novel Triplet Regimens

Is There a Role for Adjuvant Therapy in Advanced Clear Cell RCC?

Treatment Options for Advanced Clear Cell RCC in the Second-Line and Beyond

Advanced Clear Cell RCC: Optimal Selection and Sequencing of Second-Line Therapy

Novel Treatment Strategies in Non-Clear Cell Renal Cell Carcinoma

Future Directions in the Management of Renal Cell Carcinoma 